This registration page may not work well in Internet Explorer. Please use a different browser to complete your registration.

Medtech Payment Summit

September 18, 2024 8:00 AM - 4:00 PM (EDT)

Description

Our Medtech Payment Summit is a unique event that discusses various payment models and reimbursement pathways for medical devices, diagnostics and digital health products. Featuring interactive panels with medtech leaders and hospital, and payor partners, the Summit will help to clarify the payment pathways for your product and build relationships among industry peers.

Kicking off the day with an optional "Payment 101 Crash Course," the agenda will include presentations and panel discussions on various payment models featuring real-world case studies, as well as topics such as, the evolving political and legal landscape around payment policy and recent updates including the Supreme Court's recent ruling on the Chevron Deference.

This is a great program to garner actionable information about identifying and securing relevant payment pathways for your products, as well as a chance to get your questions answered by our experts.

We will provide a Uniform Certificate of Attendance for in-person attendees should you wish to apply for continuing education units (CEU). 


AGENDA

Time
Session
Speaker(s)



8:00 AMRegistration, Breakfast & Networking

8:30 AMPayment 101 (Optional)
Join us for a crash-course on payment 101! This high-level overview will equip you with payment processes, procedures and important terms             if you are not in the space or need a refresher. Come and get a CliffsNotes             version of the payment landscape for medical devices to help you navigate             conversations that will dive deeper throughout the day.
Angela Lively, Senior Advisor, Covington & Burling
10:00 AMWelcome Remarks

10:05 AMOverview of Possible Payment Models 
This session will include strategy of payment models for your medical device, to include possible payment models: reimbursement code coverage, direct to insurance/hospital, and direct to consumer.


Moderator: Rujul Desai, Partner, Covington & Burling 

Panelists: 

Michelle Fox, Corporate Vice President and Chief Medical Officer, Teleflex

Stephanie Wimmer, Global Vice President, Health Economics, Market Access, and Reimbursement (HEMAR), Philips  

 Buy Health

10:45 AMPayment Pathway: Working with CMS  
This session will highlight the payment pathway of receiving reimbursement through CMS. Presentations will be in the form of case studies.  

Ira Goldman, VP of Government Affairs, Lantheus 

Yajuan Lu, J.D., Director, Corporate Health Policy & Reimbursement, Boston Scientific  

Nick Doucette
Manager, Health Policy & Reimbursement, Novocure
11:30 AMNetworking Break
11:45 AM

What’s Next: Will Congress Act on Payment Policy after TCET?

In August, CMS released its long-awaited final guidance on the Transitioning Coverage of Emerging Technologies or TCET, capping an eight-year journey from the first introduction of a breakthrough pathway for medical devices to receive transitional coverage. However, the limited scope of TCET leaves much to be desired and it is not the game changer the device industry has been hoping for. Congress has a chance to improve the program with HR 1691, the Ensuring Patient Access to Critical Breakthrough Products Act of 2023. With just three months left in the session, and a national election ahead, will any action be taken on this critical legislation? Hear from experts on what to watch out for in this critical debate.

Lee A. Fleisher, M.D., M.L., Principal and Founder, Rubrum Advising 
12:15 PMLunch & Networking
1:15 PMWhat the Jarkesy, Chevron and Cornerpost Decisions Mean for You
Over the course of three days this summer, the U.S. Supreme Court dealt a three-punch combination to the vast array of federal agencies and sub-agencies that critics refer to as “the administrative state.”  While each case represented a significant development in its own right, the cumulative effect of all three cases will have a generational effect on the way federal agencies act, defend their rules and regulations, and operationalize their enforcement activities. Join this session to learn how this tectonic shift in federal administrative law will affect the entire healthcare system for better, or for worse.
Andrew S. Tsui, Of Counsel, Greenberg Traurig
1:45 PMPayment Pathway: Obtaining Coverage with Commercial Payors   
This session will highlight the payment pathway of receiving coverage through private insurance companies.
Michael Hill, Managing Principal, Healthcare Business Consulting,
EPAM Continuum

Chidebelu Ufodike,  Staff - U.S. Healthcare 

2:30 PMNetworking Break
2:45 PMPayment Pathway: Hospital Value Analysis Submission and New                 Therapies
This session will highlight the payment pathway of receiving payment through a hospital system. Through a moderated panel discussion, we’ll hear from decision makers at leading hospital systems and medtech companies, including how to influence their buying decisions and keys to value analysis when reviewing new therapies.
Stacey A. Bunk, MS, CPC, CCC, FABC, Director, Reimbursement & Market Access, AtriCure 

Charlie Miceli C.P.M., Strategic Advisor Network Finance, University of Vermont Health Network  

Brian Patel, Senior Vice President of Medical Affairs, Chief Medical and Quality Officer, Sturdy Hospital (invited)  
3:30 PM    Ask the Experts 
Do you have a question not covered on the agenda? This is your opportunity to ask our panel of medtech reimbursement and             policy experts your questions.  

Michael Ferguson, Ph.D., Vice President, Global Healthcare Economics and Reimbursement, AtriCure 

4:00 PMClosing Remarks


SPEAKERS

Stacey Bunk, MSc, CPC, CCC, FABC
Director of Market Access and Reimbursement
AtriCure

With over 25 years of experience in healthcare, Stacey has held leadership roles in both hospital settings and the medical device industry. Previously, she served as the Revenue Director at a large academic medical center in Boston and Vice President of a hospital system encompassing community and academic hospitals.

At a medical device company focused on cardiovascular care, Stacey led the global reimbursement strategy. She collaborated with federal agencies to establish new Diagnosis Related Groups (DRGs) as well as successfully transitioned their technology into existing DRGs that better reflected the cost of care for critically ill patients.

Stacey holds a Master's degree in Organizational Leadership, is a certified coder, and is a Fellow of the Advisory Board Company. Her career has been dedicated to advancing patient care through sustainable financial models and innovative solutions.


Rujul Desai
Partner
Covington & Burling

Rujul Desai is a Partner in Covington's Washington, DC office, where he is a member of the Health Care and Digital Health Practice Groups. He advises life science clients on novel contracting, compliance, and policy issues related to pricing, market access, and reimbursement for medical products. He brings decades of experience advising on the complex system of federal and state laws governing the healthcare industry. Rujul regularly advises drug, biologic, device, and diagnostic manufacturers on legal risk assessments involving new product launches, government and commercial pricing, PBM and payer formulary access, value-based contracting, GPO and supplier arrangements, patient access and hub services, affordability programs, e-prescribing, telehealth, digital health, and the use of health economic data and modeling.

Nick Doucette
Manager, Health Policy & Reimbursement
Novocure

Nick has developed a broad knowledge of the Reimbursement workflow in his five years with Novocure. In his most recent role, he focused on strategy and scaling opportunities including projects that led to the implementation of projects that created efficiencies supporting patients. Nick manages the relationships and coverage policy with the Department of Veterans Affairs and State Medicaid Agencies. He lives in New Hampshire with his wife, two girls, and Golden Retriever. In his free time, he enjoys teaching his girls to golf, running, and spending time by the water with family.

   

Michael Ferguson
Vice President of Healthcare Economics and Reimbursement
AtriCure

Michael is the Vice President of Healthcare Economics and Reimbursement for AtriCure, a surgical medical device company focused on treatment of atrial fibrillation. Michael has responsibility for overall reimbursement, health economics, and market access strategy. Some of his groups work and collaboration with specialty societies has resulted in new CPT and MS-DRG payment codes. Prior to his role at AtriCure he held leadership positions at Boston Scientific, Philips Healthcare, and Medtronic. 

He earned his PhD at the University Florida in Applied Physiology. 


Lee A. Fleisher, MD, ML
CEO
Rubrum Advising, LLC

Lee A. Fleisher, MD, ML (Masters in Law) is the Founding Principal and CEO at Rubrum Advising, LLC, a consulting firm dedicated to identifying strategic pathways, including regulatory counsel, to ensure the highest quality care is adopted and diffused across the healthcare sector. From July 2020-July 2023, he was the Chief Medical Officer and Director of the Center for Clinical Standards and Quality for the Centers for Medicare and Medicaid Services. He serves as a Senior Advisor of the Bipartisan Policy Center and FasterCures of the Milken Institute, Senior Fellow of the Leonard Davis Institute of Health Economics and Visiting Fellow of the Duke-Margolis Center.   He is a member of the Steering Committee of CHAI (Coalition of Health AI), consultant to the FDA Digital Health Advisory Committee and a member of the HITAC of the ONC.    From 2004 through July 2020, he was the Robert D. Dripps Professor and Chair of Anesthesiology and Critical Care and Professor of Medicine at the University of Pennsylvania and is currently Emeritus Professor and continues to practice clinically.  In 2007, he was elected to membership of the National Academy of Medicine.  

Michelle Fox
Corporate Vice President & Chief Medical Officer
Teleflex

As the Chief Medical Officer of Teleflex, Michelle Fox and her leadership team set the clinical vision and strategy for Teleflex. She provides leadership to Medical Affairs which provides medical guidance for the Company’s global product portfolio and assures compliance with global regulatory, legislative and medical requirements. Clinical Affairs representatives lead the design of and implementation of multidisciplinary clinical development programs covering a broad range of products and therapeutic areas in collaboration with strategic business partners. Michelle also leads the scientific, clinical research and reimbursement arm of the organization. Michelle’s work has focused on organizational and systems development. This includes interactive medical education, as a means to making transformational change and supporting research that implements the best medical practices into bedside clinical care. Michelle offers a rare blend of strong clinical practice and leadership, driven by her desire to improve patient outcomes, and tempered by a clear understanding of the challenges facing healthcare today.

Ira N. Goldman 

Vice President, Global Public Policy and Government Relations  

Lantheus Holdings  


Ira N. Goldman is Vice President, Global Public Policy and Government Relations, Lantheus Holdings. He is Co-Chair of the Isotope Supply Committee, Council on Radioisotopes and Radiopharmaceuticals (CORAR) and Vice-Chairman of the Security of Supply Working Group, Nuclear Medicine Europe. 

Mr. Goldman is responsible for development and execution of Lantheus’s strategy and actions for public and healthcare policy, including legislative strategy and interactions with the U.S. Congress as well as relationships with Executive Branch agencies.He coordinates Lantheus’s involvement with trade associations, business and regional advocacy groups and medical societies. He also interacts with U.S. and foreign governments and international organizations regarding medical isotope production and supply matters. 

Mr Goldman earned a Master of Arts in International Affairs (with distinction) from the Johns Hopkins University Nitze School of Advanced International Studies in Washington DC in 1980, including study at the Johns Hopkins Centre for European Studies in Bologna, Italy (1978-1979). Mr Goldman earned a Bachelor of Arts (with honours) in History and was Phi Beta Kappa at Trinity College, Hartford, Connecticut in 1978.

Michael Hill
Managing Principal, Healthcare Business Consulting
EPAM Continuum

Mr. Hill brings 25+ years of Business Value & Healthcare Transformation for health systems, health plans, and innovative healthcare companies. Prior to joining EPAM, Mike served numerous consulting and leadership roles focused on business transformation and optimizing healthcare economic and clinical outcomes through deployment of technology, data, predictive analytics, and payer and provider collaboration. 

Selected prior client organization work includes national and regional payers including Optum/UnitedHealth Group, Aetna/CVS, Blue Cross Blue Shield Plans, and others; large academic health systems, and innovative technology and value-based care companies specific to the Medicare Advantage business.



Angela (Menchaca) Lively
Senior Advisor
Covington & Burling

Angela (Menchaca) Lively is a Senior Advisor in Covington’s Health Care and Digital Health Practice Groups.  She has decades of experience analyzing, understanding and determining implications of health and reimbursement policy changes on beneficiaries, providers, health systems and manufacturers, particularly as it relates to access to new technology. Throughout her industry and consulting experience she has supported the launch of dozens of products and has spent her career understanding the intersection of coverage, coding, and reimbursement with broader health policy change and the effect of those changes on patient and provider decision making. She has particularly focused on the market access elements of health system change, coverage, coding, and reimbursement across settings of care, beneficiary protections, value determination, alternative payment models, and quality measurement.
Yajuan Lu
Director, HEMA
Boston Scientific

Yajuan Lu is a Director of the Boston Scientific Corporate HEMA team, leading the company’s corporate Medicare policy strategies. Prior to BSC, Yajuan worked at Johnson and Johnson, where she advanced through a number of roles, including Director of U.S. Coverage and Reimbursement Policy and Lead of China Health Policy. Prior to her experience with the private sector, Yajuan served in Senator Grassley’s personal office as a David A. Winston Health Policy fellows. Yajuan graduated from University of Pittsburgh School of Law, and obtained Bachelor’s degree from Peking University Health Science Center.
Charlie Miceli
Strategic Advisor for Finance
University of Vermont Health Network

Charlie Miceli Currently serves as Strategic Advisor for Finance at University of Vermont Health Network. Charlie served at University of Vermont Health Network Chief Supply Chain Officer through March 2024. 

Charlie has also served as Interim CEO for both Inter-Lakes Heath in 2010-2011 and 2014 as well as CIO for One Care Vermont and Deputy CIO and VP Pharmacy for UVM Medical Center. Prior Supply Chain roles include Chicago (Northwestern, Loyola and Univ of Chicago) and Boston (Partners Healthcare and Newton Wellesley) as well as consultancy for BD Health Care Consulting and Services.

In October 2023 he was inducted into the Bellwether League Foundation Healthcare Supply Chain Hall of Fame. He earned a B.A. in Psychology from Notre Dame.

Andrew Tsui 
Of Counsel
Greenberg Traurig 

Drawing on more than a decade of experience litigating on behalf of the U.S. Department of Health and Human Services (HHS), Office of the General Counsel for the Centers for Medicare & Medicaid Services (CMS) Division, Andrew Tsui represents healthcare providers, suppliers, and laboratories in complex, government-facing investigations, appeals, and direct litigation. Andrew also provides regulatory and compliance counsel to healthcare and life sciences companies requiring an insider’s view to the federal framework. Andrew’s recent work includes advising early-stage start-up companies in digital and AI-enhanced healthcare technologies. 

 Andrew obtained his law degree from the University of North Carolina School of Law and his Master’s of Public Health from the UNC Gillings School of Global Public Health. He graduated with high honors from Wesleyan University in Middletown, CT. 

Stephanie Nelson Wimmer, MBA, MPH
Vice President
Global Health Economics, Market Access, and Reimbursement (HEMAR)
Philips

Stephanie currently leads the Global Health Economics, Market Access, and Reimbursement (HEMAR) organization for Philips, championing patient access for Philips’s $18B product portfolio.

She previously served as the VP, Health Economics Policy, and Reimbursement for Medtronic’s Medical Surgical Portfolio where she led a suite of global shared functions including, health economics and outcomes research (HEOR), global market access strategy development and evidence planning, field reimbursement, and health policy.

Stephanie holds a Bachelor of Arts in American Studies and Religion from Hamilton College (Clinton, New York), a Master of Business Administration from the Amos Tuck School at Dartmouth College (Hanover, New Hampshire), and a Master of Public Health in Health Policy and Administration from the Mailman School at Columbia University (New York, New York). She also is a graduate of General Electric’s Financial Management Program.




SPONSORS


Pricing

$175 for member in-person tickets
$225 for non-member in person tickets 

Save $30 with early bird rates through Sept. 6!

View Event

Contact Information

Name: Nichole Owens
Email: nichole@massmedic.com
We're sorry. No registrations are currently available. You may wish to contact the event organizer for assistance.
{{ vm.EventInfo.ErrorMessage }}

Select Registration Options

Edit
{{vm.regWarningMessage}}
{{vm.regAlertMessage}}

Exhibitor Opportunities

Name Price Att Qty
{{ et.Name }}
{{ et.IncludedAttendeesCount }} {{ et.AttendeeRegType.RemainingPerType }} Remaining {{ et.AttendeeRegType.RemainingPerType * -1 }} on Waiting List {{ et.AttendeeRegType.RemainingPerType * -1 }} Over Limit
{{ et.Remaining }} Remaining
 Sold out

Attendee Registration Options Total Remaining: {{ vm.EventInfo.VacantSpotsPerEvent }}

Waiting List Available
{{ vm.stats.totalAttendeesCount }} Registered , {{ vm.OverallOverAmount() }} on Waiting List , {{ vm.OverallOverAmount() }} Over Limit
Name Price Qty
{{ rt.Name }}
{{ rt.IsMemberOnly ? ' (Members Only)' : '' }}
Limit: {{ rt.LimitPerPurchase }}
Included Attendees: {{ rt.AttendeesCountPerOneRegistration }}
{{rt.Price | currency }} {{rt.PriceAfterDiscount | currency }} {{ rt.Price | currency }}
{{ rt.RemainingPerType }} Remaining
{{ rt.RemainingPerType * -1 }} on Waiting List
{{ rt.RemainingPerType * -1 }} Over Limit

{{'[[Sponsorship]] Opportunities' | localizeString:'['}}

Name Price Att Qty
{{ st.Name }}
{{ st.IncludedAttendeesCount }} {{ st.AttendeeRegType.RemainingPerType }} Remaining {{ st.AttendeeRegType.RemainingPerType * -1 }} on Waiting List {{ st.AttendeeRegType.RemainingPerType * -1 }} Over Limit
{{ st.Remaining }} Remaining
 Sold out
Continue

Registration Information

Edit

Exhibitor - {{er.Name}}

Exhibitor #{{ $index + 1 }}

Total: {{exhibitor.TotalPrice | currency}} {{ exhibitor.IsBenefit ? "- Included as a Benefit" : exhibitor.IsDiscounted ? "- Discounts have been applied" : ""}}
Exhibitor Directory
Primary Contact
Booth Information
Additional Information
Additional Items

Attendee - {{er.Name}}

{{ att.getAttendeeTerm(vm.EventSettings.AdditionalAttendeesTerm, $index) }} #{{ att.getAttendeeIndexDisplay(vm.EventSettings.AdditionalAttendeesTerm, $index) }}

Total: {{att.TotalPrice | currency}} {{att.DiscountMessage | localizeString:'['}}
A No Show fee is being assessed for {{fee.EventName}} on {{fee.EventStartLocalTimeString}}.
More Information Less information

Address

Phone

Additional Information
Event Sessions

{{slot.Name}}

{{$select.selected.SessionName}}
(full)
{{slot.SelectedSession.SessionDescription + (slot.HasFees ? " (Price: " + (slot.PriceTotal | currency) +")" : "")}}
Additional Items

{{'[[Sponsorship+]]' | localizeString:'['}} - {{er.Name}}

{{'[[Sponsor]]' | localizeString:'['}} #{{ $index + 1 }}

Total: {{sponsor.Price | currency}}
Continue

Additional Items

Edit

{{(vm.EventInfo.Terms.Donation || "Fundraising") + " Opportunities"}}

Campaign Name Item Description Amount
{{item.CampaignName}} {{item.Description + (item.ShowMinimumPrice && item.MinimumPrice ? " (Min: " + item.MinimumPrice + ")" : "")}}
Continue

Complete Registration

Edit

Terms & Conditions

No Show Policy

{{ vm.EventInfo.EventSettings.NoShowPolicy }}

Enter Promo Code
This event is synced to a webinar so no confirmation email will be sent from GrowthZone.

Thank you to our {{'[[Sponsor+]]' | localizeString:'['}}